Medical Styrenic polymers market will surpass US$1.5 bln by 2024, as per Global Market Insights, Inc. North America will contribute substantially towards global revenue as massive expansion of medical industry propels the regional growth over 2017-2024. Pressing need to substitute plastics including PVC in the medical industry owing to its hazardous environmental implications will drive medical styrenic polymers market size by 2024. PVC is extensively utilized in the healthcare industry to create devices for storing IV solutions, blood/medicine containers, tubes and connectors owing to brilliant clarity and ability to withstand broad range of temperature conditions. However, significant amount of toxic component released from PVC which may contaminate IV fluids and migrate into human body has led to formulation of strict regulations to gradually replace these products with styrene plastic which is eco-friendly and plasticizer free making it desirable across medical & healthcare industry.
As per Zion Market Research, in the medical industry, styrenic polymers are used in the medical devices such as tubes, connectors, IV spikes, equipment housing, bags, liquid delivery systems, and medical packaging. Polystyrene, SAN, ABS, and styrenic block polymers such as SEBS and SBS are the common styrenic polymers that are used for manufacturing medical devices and packaging, thus contributing to the global market growth. Polystyrene is the widely used styrenic polymer in the medical applications while ABS co-polymer dominates the styrenic market. The processing of styrenic materials can be flexible as well as rigid as per the requirement of the end-user. Styrenic polymers provide advantages in design and development of medical parts and devices owing to their flexibility, hence widely used in the market. Additional properties such as unique bonding polarity, chemical inertness, and aesthetic and physical properties are driving this market. The fact that styrenic polymers are costly as compared to other medical polymers such as polyethylene and polyvinyl chloride may hamper the market growth. North America dominated the market for styrenic polymers for the medical applications. Asia Pacific and Europe followed North America in terms of the usage of styrenic polymers in medical applications. In the coming years, the market will be ruled by Asia Pacific owing to the rapid developments in the medical field and the growing population. The growth in the infrastructure industry will make the Asia-Pacific region to become the largest consumer of the styrenic polymers market. The production of styrenic polymers is done by the polymerization of styrene monomers and chemical compounds such as butadiene, acrylonitrile, and others. Owing to the increasing applications such as in packaging, automotive, building and construction, and appliances, the production of styrene-based derivatives is a growing trend. The traditional metallic devices are now being replaced by polymers that can be processed easily, hence the medical plastics market is expanding significantly. The polymers that contain styrene as the main component are known as styrenic polymers. Styrene is produced from ethylene and benzene. The most common styrenic polymer is polystyrene. The physical and chemical properties of styrenic copolymers depend on other monomers in the styrenic polymer chain.
IOCL PP-PE PRODUCTION SCHEDULE - OCTOBER - 2018
New Office Bearers take Charge at Plastindia Foundation...
Road from waste plastics opens in Zwolle, Holland
Indian Institute of Packaging to Inaugurate new Academi...
Investors evince interest in Manjushree
Single Component Solvent-less PU Adhesive
What's Banned, What's Not
Welset PVC Compound Business Finds Suitor in Mitsubishi...
Interpretation of revised Maharashtra Plastics Ban Noti...
Amendment Notification to Plastic Ban